Atalanta Therapeutics is a biotechnology company pioneering RNA interference (RNAi) for the treatment of intractable neurological diseases, utilizing its proprietary platform of divalent small interfering RNA (di-siRNA) to enable durable, selective gene silencing throughout the brain and spinal cord
Atalanta Therapeutics is a biotechnology company pioneering RNA interference (RNAi) for the treatment of intractable neurological diseases, utilizing its proprietary platform of divalent small interfering RNA (di-siRNA) to enable durable, selective gene silencing throughout the brain and spinal cord.